Peter Mucchetti > Clifford Chance > Washington DC, United States > Lawyer Profile

Clifford Chance
2001 K STREET NW
WASHINGTON DC 20006-1001
DISTRICT OF COLUMBIA
United States

Position

Peter Mucchetti is a partner in Clifford Chance’s Litigation and Dispute Resolution and Antitrust practices, based in Washington, DC. Peter Mucchetti specializes in antitrust litigation and competition matters. He has more than twenty-five years of antitrust litigation, investigations, and merger clearance experience, with particular expertise in the technology, healthcare, and consumer products industries.

Prior to joining Clifford Chance, Peter worked at the US Department of Justice (DOJ) Antitrust Division, where he served as the Chief of its Healthcare and Consumer Products Section. In that role, he led the Antitrust Division to its successful trial victories in highly complex cases concerning the proposed Anthem-Cigna and Aetna-Humana mergers. Peter is a Vice Chair of the Healthcare and Pharmaceuticals Committee of the ABA Antitrust Law Section and a frequent speaker on antitrust topics.

Education

Yale University (BA Economics) 1989
Harvard Law School (JD) 1995
Admitted as an Attorney-at-Law in the District of Columbia 1999
Trial Attorney, Litigation I Section, US Department of Justice, Antitrust Division 2003
Assistant Chief, Litigation I Section, US Department of Justice, Antitrust Division 2011
Chief, Healthcare and Consumer Products Section, US Department of Justice, Antitrust Division 2012
Joined Clifford Chance as a Partner 2020

Lawyer Rankings

United States > Antitrust > Merger control

Clifford Chance combines institutional relationships with major businesses and private equity funds as merger counsel with high-profile hired gun instructions from key names in fields such as healthcare, education, and consumer goods, handling cross-border strategic merger clearances as well as DOJ and FTC investigations and related litigation, with standout capabilities in acting for third parties objecting to proposed mergers and advising on multijurisdictional approvals for transactions in healthcare and life sciences. In a major development for the team, Leigh Oliver arrived from Hogan Lovells US LLP in March 2022, and promptly successfully represented UnitedHealth Group in its acquisition of Change Healthcare, a $13bn deal that faced significant scrutiny from the Antitrust Division and state attorneys general, while HSR specialist Brian Concklin was promoted to partner in May 2022. The team is led by former acting Assistant Attorney General Sharis Pozen, who has also held senior antitrust positions at the FTC and in-house, and specialises in complex merger litigation, and Timothy Cornell, a key name for multijurisdictional clearances processes and investigations. Former DOJ official Peter Mucchetti is also a key team member, with expertise in healthcare and consumer goods mandates. All lawyers mentioned are in Washington DC.